Geneva University, Switzerland

Researchers from Switzerland, the United States and the People's Republic of China publish new studies and findings in the area of head & neck cancer

Published in Medicine and Law Weekly, October 20th, 2006

New findings from Switzerland, the United States and the People's Republic of China describe advances in head & neck cancer.

Study 1: Head and neck cancer patients with severe co-morbidities, unfit to receive concomitant chemotherapy, could be treated a novel strategy that combines carbogen breathing with radical radiotherapy.

In a recent article published in the journal Clinical Oncology, scientists in Switzerland assessed "the feasibility of carbogen breathing combined with radical radiotherapy in patients with advanced head and neck cancer who are unfit to receive concomitant chemotherapy. Twenty patients (median age 66 years) with advanced...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2006-10-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry